IRLAB Therapeutics AB (publ)

OM:IRLAB A Voorraadrapport

Marktkapitalisatie: SEK 731.3m

IRLAB Therapeutics Dividend

Dividend criteriumcontroles 0/6

IRLAB Therapeutics does not have a record of paying a dividend.

Belangrijke informatie

n/a

Dividendrendement

n/a

Terugkoop Rendement

Totaal aandeelhoudersrendementn/a
Toekomstig dividendrendementn/a
Dividendgroein/a
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeeln/a
Uitbetalingsration/a

Recente dividendupdates

Geen updates

Recent updates

Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?

Oct 30
Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?

IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?

Jun 06
IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?

Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation

Jan 04
Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation

Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely

Sep 21
Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely

We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully

Mar 18
We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully

IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans

Dec 01
IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans

We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit

May 19
We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit

We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

Sep 11
We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

Apr 30
We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

Mar 19
What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth

Jan 25
We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth

Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay

Dec 21
Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay

What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

Nov 25
What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Insufficient data to determine if IRLAB A's dividends per share have been stable in the past.

Groeiend dividend: Insufficient data to determine if IRLAB A's dividend payments have been increasing.


Dividendrendement versus markt

IRLAB Therapeutics Dividendrendement versus markt
Hoe verhoudt IRLAB A dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (IRLAB A)n/a
Markt onderkant 25% (SE)1.6%
Markt Top 25% (SE)4.5%
Gemiddelde industrie (Pharmaceuticals)2.4%
Analist prognose (IRLAB A) (tot 3 jaar)n/a

Opmerkelijk dividend: Unable to evaluate IRLAB A's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hoog dividend: Unable to evaluate IRLAB A's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Winstuitkering aan aandeelhouders

Verdiendekking: Insufficient data to calculate IRLAB A's payout ratio to determine if its dividend payments are covered by earnings.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Unable to calculate sustainability of dividends as IRLAB A has not reported any payouts.


Ontdek bedrijven met een sterk dividend